A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7.2 | $261.1 | 5% |
|
| Shares Out (Mil) | 4.3 | 54.3 | 13% |
|
| Institutional Ownership | 77.5% | 92.9% | 47% |
|
| Float (Mil) | 5.1 | 41.5 | 12% |
|
| Beta | -2.03 | 0.95 | 0% |
|
| Avg Daily Volume (000s) | 96 | 677 | 34% |
|
| Price Change (52-week) |
(66.8%) | 51.8% | 11% |
|
| Growth | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (11.7%) | (10.1%) | 28% |
|
| EPS (5yr) | 18.6% | 15.8% | 66 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 2.8% | (15.6%) | 66% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.425) | ($1.925) | ($1.750) | |
| Month Ago EPS | ($0.425) | ($1.925) | ($1.750) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.455) | ($1.970) | ($2.130) | |
| Year/Year Chg | (19.7%) | (63.8%) | (64.3%) | |
| Financials | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($8) | ($43) | 31% |
|
| EPS (TTM) | ($2.783) | ($1.600) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($32) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($3) | $174 | 2% |
|
| Valuation | ACXP | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.78 | 2.52 | 15% |
|
| P/E | na | 19.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 68.9% | na |
|
| Net Margin | na | (72.5%) | na |
|
| ROA | (87.6%) | (47.5%) | 6% |
|
| ROE | (128.1%) | (54.9%) | 7% |
|
| Liabilities to Assets | 25.8% | 29.4% | 18% |
|
| F-Score | 3 | 3 | 18% |
|
Acurx Pharmaceuticals, Inc. did not pass any screens on 9/24/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
